O

Oligomerix, Inc

11 employees

Oligomerix develops target identification and validation technologies enhancing the drug discovery process for neurodegenerative diseases.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Antibody discovery
Clinical development
Pre-clinical development
Ediscovery
Target discovery and validation
Commercial development
Assay development
Medical
Drug discovery

Date founded

2006

Funding rounds raised

Total raised

$3.4M

from 3 investors over 3 rounds

O

Oligomerix, Inc raised $3.4M on August 9, 2022

Investors: National Institutes of Health

O

Oligomerix, Inc raised $1.7M on September 11, 2013

Investors: National Institutes of Health

O

Oligomerix, Inc raised $2M on April 23, 2012

Investors: Wheatley Partners

FAQ